Disease Classification on NIFD (50-50 train-test)
86AccuracyARMA
Evaluation results
| Method | Links | |||||
|---|---|---|---|---|---|---|
| ARMATrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=true2026.01 | 86 | 88.7 | 91 | 89.7 | 93.9 | |
| ChebNetTrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=true2026.01 | 85.3 | 90.5 | 87.7 | 88.9 | 93.4 | |
| GATTrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=true2026.01 | 85.1 | 78.3 | 76.9 | 77.3 | 89.5 | |
| GCNTrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=true2026.01 | 77 | 83.8 | 82.7 | 82.6 | 82.5 | |
| AE-GCNTrain-Test Split=50-50, Cross-Validation=20-fold2026.01 | 73 | 58 | 28 | 36.5 | 79.1 | |
| Random ForestTrain-Test Split=50-50, Cross-Validation=20-fold2026.01 | 72.4 | 73.9 | 91.2 | 81.6 | 79.3 | |
| MLPClassifierTrain-Test Split=50-50, Cross-Validation=20-fold2026.01 | 72.1 | 80.6 | 77.5 | 78.8 | 77.9 | |
| SVCTrain-Test Split=50-50, Cross-Validation=20-fold2026.01 | 71.7 | 76 | 85.1 | 80.1 | 76.7 | |
| XGBoostTrain-Test Split=50-50, Cross-Validation=20-fold2026.01 | 71.3 | 75.9 | 84.1 | 79.7 | 74.3 | |
| GATTrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=false2026.01 | 68.6 | 77.3 | 76 | 76.4 | 73.8 | |
| GCNTrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=false2026.01 | 66.2 | 76.8 | 72 | 73.8 | 71.4 | |
| ARMATrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=false2026.01 | 64.9 | 81.8 | 61.8 | 70.2 | 74.3 | |
| ChebNetTrain-Test Split=50-50, Cross-Validation=20-fold, Reconstruction=false2026.01 | 62.4 | 83 | 55.7 | 66.5 | 72.9 |